Loading page…
AFT Pharmaceuticals Ltd 2026 Annual Report with Sustainability Disclosures
Company: AFT Pharmaceuticals Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2026
Type: Annual Report with Sustainability Disclosures
Pages: 122
The report presents FY26 as a record year for AFT, with total revenue of $254.7 million, up 22% from FY25, and operating profit of $24.4 million. The company expanded its sustainability disclosure by voluntarily reporting Scope 3 emissions and reported consolidated FY26 location-based emissions of 2,988.00 t CO2e. It also reported 126 employees, including a workforce that was 57% women, while its quantified 42% by 2030 emissions-reduction targets applied to UK subsidiary operations.
Indicators available in this report: